Cas:284027-37-8 6-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline manufacturer & supplier

Chemical Name:6-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline

CAS.NO:284027-37-8

Synonyms:ISOQUINOLINE,1,2,3,4-TETRAHYDRO-6-(TRIFLUOROMETHYL);6-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline;Isoquinoline, 1,2,3,4-tetrahydro-6-(trifluoromethyl)-;6-trifluoromethyl-1,2,3,4-tetrahydro-isoquinoline

Molecular Formula:C₁₀H₁₀F₃N

Molecular Weight:201.188

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:228.9±35.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.476

PSA:12.03000

Exact Mass:201.076538

LogP:1.98

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like ISOQUINOLINE,1,2,3,4-TETRAHYDRO-6-(TRIFLUOROMETHYL) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-trifluoromethyl-1,2,3,4-tetrahydro-isoquinoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-trifluoromethyl-1,2,3,4-tetrahydro-isoquinoline Use and application,Isoquinoline, 1,2,3,4-tetrahydro-6-(trifluoromethyl)- technical grade,usp/ep/jp grade.

Related News: Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. 6-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline manufacturer South Korea and Japan are barring noncitizens who traveled recently to Hubei, the province at the center of the outbreak. 6-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline supplier South Korea and Japan are barring noncitizens who traveled recently to Hubei, the province at the center of the outbreak. 6-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline vendor An active pharmaceutical ingredient (API) is a substance, or a mixture of ingredients, combined in the manufacture of a pharmaceutical or drug. 6-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline factory INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.